Physician profile
Michael Kassur
NPI 1508876491
$6,617.93
in general payments reported to CMS, 2019-2025
17 companies · $22.64 in 2025
The $22.64 reported for 2025 was less than what a typical Psychiatry provider received nationally (typical 2025 total: $176).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $355 · 2020: $732 · 2021: $1,203 · 2022: $1,186 · 2023: $1,889 · 2024: $1,230 · 2025: $22.64.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,003 · Education: $139.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,002.91 |
| Education | $138.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $1,669.66 | 2019-2024 | Invega Sustenna, Invega Trinza, Spravato |
| Teva Pharmaceuticals USA, INC. | $954.76 | 2021-2024 | Uzedy, Austedo, Austedo Xr |
| Neurocrine Biosciences, INC. | $636.43 | 2019-2024 | Ingrezza |
| Sunovion Pharmaceuticals INC. | $559.40 | 2019-2022 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $515.16 | 2020-2024 | Caplyta |
| Alkermes, INC. | $505.74 | 2019-2024 | Lybalvi, Aristada, Aristada Initio |
| Abbvie INC. | $484.52 | 2021-2024 | |
| Otsuka America Pharmaceutical, INC. | $333.50 | 2019-2024 | Abilify Asimtufii, Abilify Maintena, Rexulti |
| Lundbeck LLC | $310.07 | 2019-2024 | Rexulti |
| Vanda Pharmaceuticals INC. | $236.60 | 2019-2024 | Hetlioz, Fanapt |
| Takeda Pharmaceuticals U.S.A., INC. | $184.94 | 2020-2022 | |
| Indivior INC. | $85.70 | 2023-2024 | Perseris |
| E.R. Squibb & Sons, L.L.C. | $75.66 | 2024 | Cobenfy |
| Janssen Scientific Affairs, LLC | $22.64 | 2025 | Invega Sustenna |
| Otsuka Pharmaceutical Development & Commercialization, INC. | $19.73 | 2020 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Almatica Pharma LLC | $14.42 | 2022 | |
| Neuronetics, INC. | $9.00 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Kassur listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.